Acadian Asset Management LLC Biomarin Pharmaceutical Inc Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Acadian Asset Management LLC holds 12,730 shares of BMRN stock, worth $835,087. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,730

Previous 12,113 5.09%

Holding current value

$835,087

Previous $994,000 10.26%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$69.02 - $93.84 $42,585 - $57,899	617 Added 5.09%	12,730 $892,000
Q2 2024 Aug 06, 2024	BUY	$74.43 - $92.22 $712,741 - $883,098	9,576 Added 377.45%	12,113 $994,000
Q1 2024 May 10, 2024	BUY	$83.81 - $99.0 $52,381 - $61,875	625 Added 32.69%	2,537 $221,000
Q4 2023 Feb 13, 2024	SELL	$76.22 - $98.51 $134,909 - $174,362	-1,770 Reduced 48.07%	1,912 $184,000
Q3 2023 Nov 13, 2023	BUY	$85.07 - $94.48 $141,216 - $156,836	1,660 Added 82.1%	3,682 $325,000
Q2 2023 Aug 07, 2023	BUY	$86.68 - $100.3 $175,266 - $202,806	2,022 New	2,022 $175,000
Q2 2022 Aug 09, 2022	BUY	$71.48 - $86.85 $831,240 - $1.01 Million	11,629 Added 2698.14%	12,060 $1 Million
Q1 2022 May 12, 2022	BUY	$74.28 - $92.69 $25,552 - $31,885	344 Added 395.4%	431 $32,000
Q4 2021 Feb 10, 2022	SELL	$71.72 - $91.47 $23.1 Million - $29.4 Million	-321,579 Reduced 99.97%	87 $7,000
Q3 2021 Nov 12, 2021	BUY	$74.77 - $85.47 $21.3 Million - $24.4 Million	285,148 Added 780.84%	321,666 $24.8 Million
Q2 2021 Aug 11, 2021	BUY	$75.51 - $84.79 $1.32 Million - $1.49 Million	17,527 Added 92.29%	36,518 $3.05 Million
Q1 2021 May 11, 2021	SELL	$74.73 - $90.69 $1.82 Million - $2.21 Million	-24,346 Reduced 56.18%	18,991 $1.43 Million
Q4 2020 Feb 11, 2021	BUY	$72.61 - $90.2 $1.43 Million - $1.77 Million	19,677 Added 83.17%	43,337 $3.8 Million
Q3 2020 Nov 09, 2020	BUY	$71.87 - $131.03 $221,503 - $403,834	3,082 Added 14.98%	23,660 $1.8 Million
Q2 2020 Aug 12, 2020	BUY	$79.55 - $124.22 $1.56 Million - $2.43 Million	19,596 Added 1995.52%	20,578 $2.54 Million
Q1 2020 May 11, 2020	BUY	$71.37 - $96.85 $70,085 - $95,106	982 New	982 $83,000

Others Institutions Holding BMRN

# of Institutions

629

Shares Held

178M

Call Options Held

1.98M

Put Options Held

1.17M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Biomarin Pharmaceutical Inc Transaction History